Chrystal Louis
CIK: 0002018696
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TCRX
TScan Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Louis Chrystal
Louis Chrystal (SEC CIK 0002018696) files insider reports with the SEC as Chief Medical Officer of TScan Therapeutics, Inc. (TCRX).
Signal8 holds 2 ownership filings by Louis Chrystal, all Form 4s, filed between Feb 11, 2025 and Jan 22, 2026. Those filings report 2 transactions, from Jan 3, 2025 to Jan 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Louis Chrystal's filings is in WALTHAM, MA.
Recent filings by Louis Chrystal
Other insiders filing for TScan Therapeutics, Inc. (TCRX)
- MacBeath Gavin, Chief Executive Officer
- ZDRAVESKI ZORAN
- BAKER BROS. ADVISORS LP, Director
- Woods Keith, Director
- Nicholson Garry A, Director
- Gruia Gabriela, Director